-
The domestic medical device industry has ushered in a harvest period, and the news of approval has been continuous in recent days
Time of Update: 2023-01-01
On November 29, the new industry announced that the company recently received three "Medical Device Registration Certificates" issued by the Guangdong Provincial Drug Administration.
-
Fujian medicine collection and procurement baked! Determine the sales limit price, and discount the medical insurance payment standard
Time of Update: 2023-01-01
Organize the signing of contracts (1) The health department leads the public medical institution, the medical insurance department leads the military medical institution, and the selected enterprise and its designated distribution enterprise sign a tripartite purchase and sales contract according to the selected price and agreed purchase quantity.
-
High-risk classic Hodgkin lymphoma (cHL) first-line treatment! US FDA approves CD30-targeted drug Adcetris: treatment of pediatric patients aged ≥ 2 years old!
Time of Update: 2023-01-01
S. Food and Drug Administration (FDA) has approved CD30-targeted antibody drug conjugate (ADC) Adcetris (brentuximab vedotin, bentuximab for injection): plus standard of care dose intensive chemotherapy AVE-PC (doxorubicin, vincristine, etoposide, prednisone, cyclophosphamide) for the treatment of pediatric patients 2 years of age and older with previously untreated high-risk classical Hodgkin lymphoma (cHL).
-
The metallurgical treatment of Alzheimer's disease may usher in a new breakthrough, and a number of new drugs under development disclose phase III clinical results
Time of Update: 2023-01-01
Eli Lilly On November 30, Eli Lilly also announced all primary and secondary endpoints of the 6-month Phase III trial of the drug Donanemab, providing the first Aduhelm head-to-head comparison for amyloid plaque clearance in patients with early-stage symptomatic Alzheimer's disease.
-
Interpretation of the policy of the Measures for Reporting Rewards for the Illegal Use of Medical Security Funds
Time of Update: 2023-01-01
Recently, the National Health Insurance Administration and the Ministry of Finance jointly formulated the Measures for Reporting Rewards for the Illegal Use of Medical Security Funds (hereinafter ref
-
After the issuance of the new regulations on online sales of prescription drugs, what is the impact on drug retail enterprises?
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];From December 1, the State Medical Products Administration issued the "Drug Online Sales Prohibition List (First Edition)" officially implemented, which means that the domestic pharmaceutical retail industry has ushered in an era of supervision.
-
Take the medical alliance as the carrier to do a good job in the graded diagnosis and treatment work plan of new coronary pneumonia
Time of Update: 2023-01-01
According to the website of the National Health Commission on December 7, the comprehensive group of the joint prevention and control mechanism of the State Council to respond to the new coronavirus
-
Beijing issued expert guidelines on community health management for people with new crown-positive infections
Time of Update: 2023-01-01
2. Assessment guidance (1) Asymptomatic infection If a positive test has been detected but there are no relevant clinical symptoms (such as fever, cough, sore throat and other self-perceived or clinically identifiable symptoms and signs), health education can be given, including health education such as how to ventilate, disinfection, hand hygiene, as well as TCM characteristic guidance and intervention such as living adjustment, diet guidance, exercise guidance, emotional adjustment, and Chinese medicine prevention.
-
Pharmaceutical companies are optimistic about the development opportunities in the field of biomedicine and are vigorously building innovative production bases
Time of Update: 2023-01-01
With the in-depth development of a new round of scientific and technological revolution and industrial transformation, the global life sciences are changing with each passing day, biotechnology is ac
-
Recently, there has been frequent good news from pharmaceutical companies in the field of anti-tumor drugs
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];Based on the huge population base, as well as the aging of aging, consumption and other factors, the global oncology drug market is growing, according to data, it has increased from 83.
-
In the trillion-dollar health market, pharmaceutical companies are also increasing their layout
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];Health is a global health concept proposed in response to the development of the times, social needs and changes in the disease spectrum, and under the impetus of multiple favorable factors such as policy guidance, public health needs, and health awareness improvement, the development of China's health industry is continuing to improve.
-
The Work Plan for Strengthening Vaccination of the Elderly against the New Coronavirus was issued
Time of Update: 2023-01-01
The joint prevention and control mechanism of the State Council today issued the "Work Plan for Strengthening the New Coronavirus Vaccination of the Elderly", requiring adherence to the principle of "due diligence"; Adhere to the government's leadership, departmental linkage, and implement territorial management responsibilities; Adhere to accurate investigation and fine management; Insist on optimizing services and providing convenience; Persist in taking multiple measures at the same time and strengthen mobilization; Persist in strengthening supervision and promoting implementation.
-
The contrast agent market is rising again: China Resources Shuanghe new products are approved Hengrui a variety to go to sea
Time of Update: 2023-01-01
It is reported that recently, there has been new news in the contrast agent market, such as China Resources Shuanghe issued an announcement that the octafluoropropane lipid microsphere injection declared by the company as a domestic agent has obtained the "Drug Registration Certificate" of the National Medical Products Administration; Hengrui Pharmaceutical issued an announcement that the company's application for gadolinium butrol injection (ANDA, that is, the US generic drug application) was approved by the US Food and Drug Administration (FDA).
-
Innovative drugs have both opportunities and challenges, and two core logics deserve attention
Time of Update: 2023-01-01
GF Securities also mentioned the above two types of enterprises, the bank pointed out that if Biotech truly becomes an international Big Pharma, its core is still to build product competitiveness, develop new drugs for unmet clinical needs, and also have global development and even commercialization capabilities.
-
Pharmaceutical companies are vigorously building aseptic production lines, and aseptic filling equipment is ushering in new opportunities for development
Time of Update: 2023-01-01
Pharmaceutical companies vigorously build aseptic production lines, pharmaceutical machine companies usher in new opportunities (Image source: Pharmaceutical Network) However, in the process of drug production, including air, personnel and other pollution sources will inevitably bring hidden dangers to the sterile environment, so sterilization and disinfection is a crucial link.
-
The retail market has exploded en masse! Ali, JD.com, chain stock prices soared!
Time of Update: 2023-01-01
Under the epidemic, people's demand for online drug purchase has surged, Internet medical care has gradually cultivated new consumption habits, and the scale of user base is increasing day by day.
-
With the continuous promotion of centralized procurement, the competition in the tens of billions of stapler market is constantly intensifying
Time of Update: 2023-01-01
Therefore, at present, in the face of centralized procurement price reduction and fierce market competition, domestic head stapler companies are increasing research and development, laying out a new generation of stapler products, upgrading processes, improving production levels, and moving towards the high-end market.
-
The development of the API market continues to improve, what is the impact on pharmaceutical enterprises?
Time of Update: 2023-01-01
epilogue epilogue In general, in the context of the broad prospects of the API industry, API equipment companies will undoubtedly usher in new development opportunities.
In general, in the context of the broad prospects of the API industry, API equipment companies will undoubtedly usher in new development opportunities.
-
The amount of new traditional Chinese medicine drugs is imminent, and the industry is optimistic about the traditional Chinese medicine enterprises that gnaw the "hard bones" under the research
Time of Update: 2023-01-01
js?cdnversion='+~(-new Date()/36e5)];In recent years, with the acceleration of the review and approval of innovative Chinese medicine drugs and the implementation of a number of substantial favorable policies for traditional Chinese medicine, China's innovative drug industry has developed rapidly, and the approval of new drugs has been increasing, since 2017, a total of 19 innovative traditional Chinese medicine drugs have been approved, of which 8 products have been approved for marketing in 2021, a record number.
-
The epigenetics track is on the rise, and Merck, BMS, etc. are increasing their layout
Time of Update: 2023-01-01
Therefore, epigenetic enzymes have gradually become an important target for drug discovery and development, and at the same time, this field is constantly attracting the attention and investment of large pharmaceutical companies.
